Cite
MLA Citation
F Cattel et al.. “Economic impact of antifungal treatment in IFD by Candida species: anidulafungin administration as a cost-effective alternative for critical care patients.” European journal of hospital pharmacy, vol. 22, no. 1, 2015, pp. 12–17. http://access.bl.uk/ark:/81055/vdc_100135174527.0x000002